Navigation Links
Kalen Biomedical, LLC Signs Distribution Agreement with Beijing LeBo Biological
Date:9/8/2013

Montgomery Village, MD (PRWEB) September 08, 2013

Kalen Biomedical, LLC (http://www.kalenbiomed.com) is pleased to announce a distribution agreement with LeBo Biological in Beijing.

Kalen Biomedical, LLC is pleased to offer premium lipoprotein products to Chinese researchers through Beijing LeBo Biological. "LeBo Biological contributes professional support along with premium products for their customers," said Kathy K. Foxx, President of Kalen Biomedical. "We are pleased to work with LeBo Biological in advancing innovative scientific discoveries.”

About Kalen Biomedical, LLC
Kalen Biomedical is a biotechnology company focused on the production of essential products for cardiovascular research. Kalen’s flagship lipoprotein product line is manufactured to exacting standards of quality using tested raw materials. Our products include native, oxidized, acetylated, and labeled human lipoproteins. The products are supported by Kalen’s expert research team and are backed by our performance guarantee. At Kalen Biomedical, we are committed to consistently providing you with products that will meet your research needs. We pride ourselves on being the partner of choice for cardiovascular research products.

About LeBo Biological
Beijing LeBo Biological (http://www.lab-bio.com) has experienced professionals providing quality products in support of the new science and technology enterprise. LeBo Biological serves more than thirty provinces and cities in China and offers products from internationally known manufacturers. The products include antibodies, peptides, cytokines, small molecules, phospholipids, and more reagents for life sciences. We supply - We care.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. CHADS2 risk score assigns over one-third of stroke patients to low or intermediate stroke risk
2. InventHelp® Client Patents “Clemmie Johnson Designs” – Pants Would Provide Warmth, Comfort and Fashion
3. Dress Company 4leafcity.com Announces Its New Arrival – New Designs Of Hot Clubwear Dresses
4. InventHelp® Client Designs Modified Razor Allows for Easier Shaving of Hard-To-Reach Body Areas (HLW-1026)
5. New Designs of iPhone 5 Silicone Cases Are Now Available at 4leafcity.com
6. Vital Signs Monitoring Market to Reach $4,375 Million by 2018 at a 6.61% CAGR - New Report by MarketsandMarkets
7. InventHelp® Client Designs a Way to Protect Against Chewing-Tobacco Toxins and Stains (DVR-569)
8. Midbrook Medical Designs First Ever Method to Help Sterile Processing Technicians Improve Efficiency in Cleaning Robotic Surgical Instrumentation
9. Pulse Oximeters Dominate Vital Signs Monitoring Market: New Research Report at RnRMarketResearch.com
10. OdorNo® Signs Exclusive Agreement with BaseCamp™: Licensing of OdorNo® Technology for BaseCamp™ Odor Barrier Bags™ for Camping, Fishing, Hunting and the Outdoors
11. PRESENT e-Learning Systems Signs Definitive Agreements to Host the Superbones East Conference for 2014 and 2015 in Orlando, Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... Academy, senescent is he who "begins to age". But ... is senescence not a synonym of ageing, it is ... is such a badly named physiological process that those ... another name. That is the case of Manuel Serrano, ... of the world,s leading experts on senescence, who has ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 The ... & Services [Physical Security, Life Safety, Facility Management], ... Worldwide Forecast & Analysis (2014 - 2019)” defines ... with an in-depth analysis and forecasting of revenues. ... market, various restraints and opportunities impacting it, along ...
(Date:7/14/2014)... into an agreement with one of the world,s ... candidates for the detection and treatment of cancer. ... antibody discovery and Roche,s expertise in developing monoclonal ... of improved treatment for cancer, a leading cause ... use of BTI,s discovery of a new mechanism ...
(Date:7/14/2014)... Secure Decisions, a leading provider of assessment ... Software Assurance Marketplace (SWAMP) to build a powerful and ... everyday life. , The SWAMP, implemented by a group ... Institute for Research, is funded by the Department of ... by building a free facility with a diverse repository ...
(Date:7/14/2014)... with improving vision, cataract surgery may slow mental decline ... dementia, a new study suggests. Better eyesight also ... "These preliminary results indicate that improved vision can have ... their loved ones, both visual and non-visual," said Dr. ... Hospitals Case Medical Center, in Ohio. Cataract surgery ...
Breaking Medicine News(10 mins):Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 2Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 3Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 4Health News:A*STAR partners Roche to develop new cancer therapeutics 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 3Health News:Cataract Surgery a Plus for Someone With Dementia, Study Says 2
... , Preliminary research on Fusarium , a group ... animals, shows how these microbes travel through the air. ... preliminary research, there will be a better understanding about ... biologists are steering their efforts towards a new aerobiological ...
... malaria vaccine that uses the entire malaria parasite has proven ... in a clinical trial, according to a new study co-authored ... Center for Vaccine Development. The vaccine is unique in that ... vaccines consist of just one or at most a few ...
... Institute in Boston and the Scripps Research Institute in ... powerful anti-diabetic effects, yet apparently free at least ... current diabetes medications. The researchers say that their ... 2 diabetes, which affects more than 25 million children ...
... HealthDay Reporter , FRIDAY, Sept. 9 (HealthDay News) -- ... were to meet Friday to discuss problems linked to ... Boniva and Reclast. These drugs, known as ... osteoporosis. But researchers have linked long-term use with a ...
... HealthDay Reporter , THURSDAY, Sept. 8 (HealthDay News) -- Many ... infant. But sometimes that concern develops into an obsession over ... that condition postpartum obsessive compulsive disorder. It can drive women ... true, such as endlessly washing the infant to stave off ...
... at the University of Ottawa Heart Institute (UOHI) have ... and exports cholesterol from cells. A team ... Biology Laboratory, UOHI, has shown that autophagy, a pathway ... accumulated in artery walls. This process facilitates the removal ...
Cached Medicine News:Health News:Microbes travel through the air; it would be good to know how and where 2Health News:Microbes travel through the air; it would be good to know how and where 3Health News:Whole-parasite malaria vaccine shows promise in University of Maryland School of Medicine clinical trial 2Health News:Whole-parasite malaria vaccine shows promise in University of Maryland School of Medicine clinical trial 3Health News:Whole-parasite malaria vaccine shows promise in University of Maryland School of Medicine clinical trial 4Health News:Whole-parasite malaria vaccine shows promise in University of Maryland School of Medicine clinical trial 5Health News:New twist in diabetes drugs could reduce life-threatening side effects 2Health News:New twist in diabetes drugs could reduce life-threatening side effects 3Health News:Osteoporosis Drugs' Safety Subject of FDA Panel 2Health News:Osteoporosis Drugs' Safety Subject of FDA Panel 3Health News:When Protecting Baby Becomes an Obsession 2Health News:When Protecting Baby Becomes an Obsession 3Health News:Researchers find process that clears cholesterol and could reverse major cause of heart attack 2
(Date:7/14/2014)... 14, 2014 /PRNewswire-iReach/ -- Harmony Foundation, Colorado,s ... Estes Park , will break ground for a new ... am on Harmony,s campus. The public is welcome to attend ... of Harmony,s $10 million Support & Renew Capital Campaign ... and complex addiction rates in Colorado . ...
(Date:7/14/2014)...  More than any other generation, Millennials born in the ... but their eyes don,t. These mobile devices demand a type ... eye has not evolved to cope with them. The gap ... comfortably often results in tired eyes, focusing problems, headaches and ... Now ZEISS has invented a new type of lens for ...
(Date:7/14/2014)...  GenSpera, Inc. (OTCQB: GNSZ), a leader in ... announces that Kareg Corporation,s Director of Research, ... research report on  the company. ... Kareg Corporation, Initiating Coverage with a Speculative Buy ... http://www.genspera.com/press/140711_Genspera_research_report_July2014.pdf GNSZ is attractive ...
Breaking Medicine Technology:Harmony Foundation Breaking Ground on Addiction Health Center 2New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 2New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 3Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 2Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 3Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 4Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 5Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 6
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... We offer a complete line ... laboratorians state-of-the-art monoclonal and monoclonal/polyclonal ... detection of enteric pathogens in ... products for Clostridium difficile, Entamoeba ...
Medicine Products: